4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-15-003491
CIK 0001369786operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 3:58 PM ET
Size
7.6 KB
Accession
0001181431-15-003491
Insider Transaction Report
Form 4
Logerfo Michael
Chief Legal Officer
Transactions
- Award
Common Stock
2015-02-25+4,420→ 48,243 total - Award
Stock Option to Buy
2015-02-25+8,208→ 8,208 totalExercise: $27.15Exp: 2025-02-25→ Common Stock (8,208 underlying)
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.
- [F2]The option vests in four equal annual installments beginning on February 25, 2016.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 3:58 PM ET
- Size
- 7.6 KB